Posted in | News

DuPont Photonics Product Passes Telcordia Qualifications

Sep 8 2004

Related Stories

DuPont wholly owned subsidiary DuPont Photonics Technologies announced that its iVOA™ family of integrated variable optical attenuators (VOA) has successfully completed all reliability tests based on Telcordia GR-1221-CORE and GR-1209-CORE guidelines. The iVOA™ has met or exceeded all relevant Telcordia standards.

"We are extremely pleased with the VOA performance achieved during these Telcordia tests," said Dr. Louay Eldada, chief technology officer and vice president of engineering – DuPont Photonics. "These results, together with the results from our extreme temperature, optical power and electrical power tests, clearly demonstrate the robustness of our design and the reliability of our products."

For more information on photonics, click here.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
(Logout)
Your comment type
Submit

Sponsored Content

Editorial Highlights

The Current State of the Global Semiconductor Market

The Current State of the Global Semiconductor Market

The global semiconductor market has entered an exciting period. Demand for chip technology is both driving the industry as well as hindering it, with current chip shortages predicted to last for some time. Current trends will likely shape the future of the industry, which is set to continue to show

How are Graphene Batteries Made?

How are Graphene Batteries Made?

The primary distinction between graphene-based batteries and solid-state batteries lies in the composition of either electrode. Although the cathode is commonly changed, carbon allotropes can also be employed in fabricating anodes.

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback